MUC4 and metastatic malignant neoplasm in the lymph nodes: Gao et al. [31] reported that MUC4 suppresses EMT in lung adenocarcinomas by modulating β-catenin, and that MUC4 expression correlates with a risk of lymph node metastasis in a cohort of 20 lung adenocarcinoma patients.